EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Quercetin: A Promising Candidate for the Management of Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD)

Julia Markowska, Kamila Kasprzak-Drozd iD, Przemysław Niziński iD, Magdalena Dragan, Adrianna Kondracka, Ewa Gondek iD, Tomasz Oniszczuk iD, Anna Oniszczuk iD

Molecules · 06.11.2024 · 29 (22) · 5245

DOI: 10.3390/molecules29225245 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Molecules, online erschienen am 06.11.2024. Verfasst von Julia Markowska und 7 weiteren Autor:innen. Beteiligte Einrichtung: Science Circle of the Department of Inorganic Chemistry, Medical University of Lublin, Dr. Witolda Chodźki 4a, 20-093 Lublin, Poland. Hauptthemen laut MEDLINE: Antioxidants, Non-alcoholic Fatty Liver Disease, Quercetin. Die Arbeit wurde bisher 32-mal zitiert (Crossref) und nennt 130 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Metabolic dysfunction-associated steatotic liver disease (MASLD) represents a chronic liver disease. The development of MASLD is influenced by a multitude of diseases associated with modern lifestyles, including but not limited to diabetes mellitus, hypertension, hyperlipidaemia and obesity. These conditions are often consequences of the adoption of unhealthy habits, namely a sedentary lifestyle, a lack of physical activity, poor dietary choices and excessive alcohol consumption. The treatment of MASLD is primarily based on modifying the patient’s lifestyle and pharmacological intervention. Despite the absence of FDA-approved pharmacological agents for the treatment of MASLD, several potential therapeutic modalities have demonstrated efficacy in reversing the histopathological features of the disease. Among the botanical ingredients belonging to the flavonoid group is quercetin (QE). QE has been demonstrated to possess a number of beneficial physiological effects, including anti-inflammatory, anticancer and antifungal properties. Additionally, it functions as a natural antioxidant. Preclinical evidence indicates that QE may play a beneficial role in reducing liver damage and improving metabolic health. Early human studies also suggest that QE may be an effective treatment for MASLD due to its antioxidant, anti-inflammatory, and lipid-regulating properties. This review aims to summarize the available information on the therapeutic effects of QE in MASLD.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AntioxidantsNon-alcoholic Fatty Liver DiseaseQuercetinAnimalsHumansAnti-Inflammatory AgentsFatty LiverMetabolic Diseases

Stichwörter der Autor:innen

antioxidantsfunctional foodmetabolic dysfunction-associated steatotic liver disease (MASLD)nutraceuticalsoxidative stresspolyphenolsquercetin

Substanzen

Anti-Inflammatory AgentsAntioxidantsQuercetin

Autor:innen und Institutionen

  • Science Circle of the Department of Inorganic Chemistry, Medical University of Lublin, Dr. Witolda Chodźki 4a, 20-093 Lublin, Poland.
  • Department of Inorganic Chemistry, Medical University of Lublin, Dr. Witolda Chodźki 4a, 20-093 Lublin, Poland.
  • Department of Pharmacology, Medical University of Lublin, Radziwiłłowska 11, 20-080 Lublin, Poland.
  • Department of Obstetrics and Pathology of Pregnancy, Medical University of Lublin, 20-081 Lublin, Poland.
  • Department of Food Engineering and Process Management, Institute of Food Science, Warsaw University of Life Sciences, Nowoursynowska 159C, 02-776 Warsaw, Poland.
  • Department of Thermal Technology and Food Process Engineering, University of Life Sciences in Lublin, Głęboka 31, 20-612 Lublin, Poland.

ORCID-Profile: Kamila Kasprzak-Drozd, Przemysław Niziński, Ewa Gondek, Tomasz Oniszczuk, Anna Oniszczuk

Zitieren

APA

Markowska, J., Kasprzak-Drozd, K., Niziński, P., Dragan, M., Kondracka, A., Gondek, E., Oniszczuk, T., & Oniszczuk, A. (2024). Quercetin: A Promising Candidate for the Management of Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD). Molecules, 29(22), 5245. https://doi.org/10.3390/molecules29225245

Vancouver

Markowska J, Kasprzak-Drozd K, Niziński P, Dragan M, Kondracka A, Gondek E, et al. Quercetin: A Promising Candidate for the Management of Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD). Molecules. 2024;29(22):5245. doi:10.3390/molecules29225245

BibTeX
@article{Markowska2024,
  author = {Markowska, Julia and Kasprzak-Drozd, Kamila and Niziński, Przemysław and Dragan, Magdalena and Kondracka, Adrianna and Gondek, Ewa and Oniszczuk, Tomasz and Oniszczuk, Anna},
  title = {Quercetin: A Promising Candidate for the Management of Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD)},
  journal = {Molecules},
  year = {2024},
  volume = {29},
  number = {22},
  pages = {5245},
  doi = {10.3390/molecules29225245}
}
Kostenlos starten →